Celldex Therapeutics' (CLDX) CEO Anthony Marucci on Q2 2015 Results - Earnings Call Transcript

Aug. 10, 2015 8:18 PM ETCelldex Therapeutics, Inc. (CLDX)
SA Transcripts profile picture
SA Transcripts
133.98K Followers

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Q2 2015 Earnings Conference Call August 10, 2015 4:30 PM ET

Executives

Sarah Cavanaugh - Vice President of Investor Relations & Corp Communications

Anthony Marucci - President and Chief Executive Officer

Avery Catlin - Senior Vice President, Chief Financial Officer and Secretary

Thomas Davis - Executive Vice President and Chief Medical Officer

Tibor Keler - Founder, Executive Vice President and Chief Scientific Officer

Analysts

Christopher Marai - Oppenheimer & Co. Inc.

Boris Peaker - Cowen and Company

Joe Pantginis - Roth Capital Partners

Seamus Fernandez - Leerink Partners LLC Equity Research

Biren Amin - Jefferies & Company

David Nierengarten - Wedbush PacGrow

Operator

Good day, ladies and gentlemen. And welcome to the Celldex Therapeutics Second Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded.

I would now like to introduce your host for today’s conference, Sarah Cavanaugh. Please go ahead, Ms. Cavanaugh.

Sarah Cavanaugh

Thank you. And thank you all for joining us. Before we begin our discussion, I’d like to mention that today’s speakers will be making forward-looking statements.

Such statements reflect on current views with respect to future events that are based on assumptions and subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.

Certain of the factors that might cause Celldex’s actual results to differ materially from those in the forward-looking statements include those set forth under the headings Risk Factors and Management’s Discussion and Analysis of Financial Condition and Results of Operations in Celldex’s Annual Report on Form 10-K, quarterly reports on Form 10-Q, and its current reports on Form 8-K, as

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.